Food and drug companies have expressed optimism, but the new health secretary and his MAHA movement will likely make waves.

Pfizer announced Jeffrey Legos, PhD, MBA as its new chief oncology officer. Bluejay Therapeutics announced Mary Cromwell, PhD, has joined its leadership team as SVP and head of technical operations.

As the Q4 2024 pharma earnings period rolls on through the first month of President Donald Trump’s second term, executives ...

A private boarding school in rural western Massachusetts that opened in the 19th century is receiving a $50 million bequest ...

Aspira Women's Health Inc. (NASDAQ:AWH), a company specializing in diagnostic substances, has announced significant changes in its executive team. Dr. Sandra Milligan, the President of Aspira, will ...

Investors are undervaluing promising drug candidates on the horizon for the two pharma giants, write Yale SOM’s Jeffrey ...

Welcome to the Wall Street Week newsletter, bringing you stories of capitalism about things you need to know, but even more ...

The pharmaceutical giant named Jeffrey Legos the head of a division it is counting on to overcome investor pressure and grow ...

In mid-2024, the commercial president of Pfizer’s oncology unit Suneet Varma announced his retirement after 15 years with the ...

Pfizer CEO Albert Bourla told investors he dined with RFK Jr, a vaccine skeptic and nominee to head HHS. They discussed ...